Home > Healthcare > Pharmaceuticals > Finished Drug Form > Platelet and Plasma Market

Platelet and Plasma Market Size

  • Report ID: GMI2737
  • Published Date: Jun 2020
  • Report Format: PDF

Platelet and Plasma Market Size

Platelet and Plasma Market size was more than USD 6.1 billion in 2019 and will witness 2.2% CAGR during 2020 to 2026. Platelet and plasma are critical parts of the treatment for several serious health problems. Platelets are tiny cell components of blood that helps in formation of blood clot to stop bleeding while plasma is a liquid component of blood that takes hormones, nutrients, and proteins to the different parts of body.

 

Increasing demand of platelet and plasma for the treatment of life-threatening diseases and deficiencies such as hemophilia, thrombocytopenia, coagulation factor deficiencies, liver disease along with other blood disorders will upsurge the industry growth. Favourable reimbursement policies in developed countries will further boost market demand over the projected timeline.
 

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of platelet and plasma valued over USD 6.1 billion in 2019.

The industry share of platelet and plasma is projected to expand at 2.2% CAGR during up to 2026.

The platelet segment accounted for nearly USD 4.1 billion market value in 2019.

Hemophilia segment accounted for around 5.5% market share in 2019.

North America platelet & plasma market will witness over 1.5% CAGR during 2020-2026.

Platelet & Plasma Market Scope

Buy Now


Premium Report Details

  • Base Year: 2019
  • Companies covered: 10
  • Tables & Figures: 91
  • Countries covered: 14
  • Pages: 110
 Download Free Sample